Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2025 ,inter alia, to consider and approve 1) To consider and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals (formerly Trimurthi Limited) has informed BSE that its Board of Directors will meet on Thursday, 11 December 2025 at 5:00 PM at the registered office in Hyderabad. The key item on the agenda is to consider and approve the issuance of securities of the Company on a preferential basis, subject to regulatory and shareholder approvals. The Board will also adopt the draft notice for an Extra Ordinary General Meeting (EOGM), fix the EOGM's date/time/venue, and appoint a scrutinizer for the e-voting process. The trading window for designated persons and their relatives has been closed from 8 December 2025 until 48 hours after the announcement is made public, in line with insider trading rules.
This signals a potential equity raise via preferential allotment, which could dilute existing shareholders' holdings depending on the size and pricing. Retail investors should watch for the detailed terms (issue price, number of shares, and identity of allottees) once disclosed post-board meeting, and prepare for an upcoming EOGM vote on the proposal.